Mycova : Actualité Mycova en direct - P1 | Bourse Reflex
Accueil > Tags > Mycova

  • Toutes les actualités en rapport avec « Mycova »

03/10 20:05 Mycova - Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

12/09 08:15 Mycova - Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

05/08 09:00 Mycova - Apricus Biosciences Provides Corporate Mid-Year Update

27/06 16:00 Mycova - Apricus Biosciences Reports Reanalysis of Its U.S. Phase III Trials for MycoVa(TM) Showing Drug is Effective in Mycological Cure Resulting in Eradication of Nail Fungus

03/06 14:00 Mycova - Apricus Bio CEO to Present Commercialization Plans for Vitaros(R) at Jefferies 2011 Global Healthcare Conference

24/05 08:55 Mycova - Apricus Biosciences to Present at the Euro-Biotech Partnering Forum 2011 to Further Its Partnership Efforts

20/05 16:00 Mycova - Apricus Biosciences CEO is Interviewed on CDTV.net

05/04 18:55 Mycova - Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

10/03 16:00 Mycova - Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

01/03 15:15 Mycova - Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

10/02 16:15 Mycova - Apricus Biosciences to Present Review of Commercialization Plans for Vitaros(R) and Development of Product Pipeline at BioPartnering North America Conference(TM)

19/01 17:45 Mycova - Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Therapy, Loceryl(R)